Last week the United States Preventive Services Task Force (USPSTF) released its fifth report to Congress highlighting women’s health as a high priority gap in clinical preventative services. Recognizing the … Continued
(December 4, 2015) According to the results of a phase III trial of over 1,000 women, women with advanced ovarian cancer gained significant delays in the progression of their disease … Continued
2015 marks the 10th anniversary of the Colorado Ovarian Cancer Alliance (COCA), an organization dedicated to promoting awareness and early detection of ovarian cancer through advocacy and education efforts, while … Continued
In September, a group of ladies from Collierville, TN hosted their first Teal Tea Luncheon to support the Ovarian Cancer National Alliance. The community event included tea, lunch and speaker … Continued
(December 2, 2015) Research funded in part by an OCRF grant to Rachel Grisham, MD has identified new, potentially targetable mutations in patients with low grade serous ovarian cancer. Dr. … Continued
(December 1, 2015) Research funded in part by Ovarian Cancer Research Fund, and published in PNAS, offers new insights into how ovarian cancer grows—and the potential to stop it. Can … Continued
(November 20, 2015) A study published in BMC Cancer demonstrates that ovarian cancer patients who had a history of oral contraceptive use had better outcomes than those who had not … Continued
(Nov. 19, 2016) In research published this month in Gynecologic Oncology, a group of Canadian researchers have found that long-term survival is not associated with BRCA mutation status in ovarian … Continued
November 18, 2015 Contact: Lisa Mauti lmauti@ovariancancer.org Public health evidence points to need for FDA regulation of laboratory developed tests “The consequences of inaccurate test results, such as false positives, … Continued
Washington, DC — On November 17th, the Food and Drug Administration (FDA) released a report: The Public Health Evidence for FDA Oversight of Laboratory Developed Tests: 20 Case Studies, that outlines the … Continued
OCRF has awarded $5.2 million in new grants, bringing our total investment in ovarian cancer research to nearly $70 million.
A new study of ovarian cancer cells from the University of Michigan Comprehensive Cancer Center, funded in part by an OCRF grant to Dr. Weiping Zou, reveals molecular changes within … Continued
Get email updates about research news, action alerts, and ways to join the fight.
